Real-world Biologics in Generalized Myasthenia Gravis: Evidence for Reduced Hospitalization Rates (P11-9.007)

June 9, 2026Neurology

View at Publisher

Ask AI

Bookmark

Share

Key Points

This research aims to evaluate how biologic therapy affects hospitalization rates in patients with generalized myasthenia gravis.
Analyzed within-patient data to estimate the association between biologic therapy and hospitalization rates.
Focused on adults diagnosed with generalized myasthenia gravis.
Found a significant reduction in hospitalization rates for patients receiving biologic therapy compared to those who were not.
Suggests that biologic therapy may lead to better health outcomes for individuals with generalized myasthenia gravis.

Answers are grounded in this paper and cite their sources.

Estimation of hospitalization rates with biologic therapy in adults with generalized myasthenia gravis, indicating potential benefits.

To estimate the within-patient association between biologic therapy and hospitalization rates among adults with generalized myasthenia gravis (gMG).

No takes yet. Share an insight, caveat, or question.

Mahler et al. (2026) studied this question.

View at Publisher

Ask AI

Bookmark

Share